Medline Inc. (MDLN) EBITDA

Annual EBITDA:

$3.20B+$807.00M(+33.70%)
December 1, 2024

Summary

  • As of today, MDLN annual EBITDA is $3.20 billion, with the most recent change of +$807.00 million (+33.70%) on December 1, 2024.
  • During the last 3 years, MDLN annual EBITDA has risen by +$1.40 billion (+77.59%).
  • MDLN annual EBITDA is now at all-time high.

Performance

1-Year Change

+33.7%

3-Year Change

+77.59%

5-Year Change

+77.59%

15-Year Change

+77.59%

MDLN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

96.88%
MDLN annual EBITDA is higher than 96.88% of companies in Healthcare sector

Range

All-Time High

$3.20B
MDLN annual EBITDA is currently at an all-time high

3-Year Low

$1.80B
MDLN annual EBITDA is currently +77.59% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
MDLN previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

Dec 25, 2025
MDLN next annual earnings announcement is scheduled for Dec 25, 2025

OtherMDLNincome statement metrics

Annual Revenue

$25.51B
MDLN annual revenue is $25.51 billion

Annual Net Income

$1.20B
MDLN annual net profit is $1.20 billion

Annual EBIT

$2.23B
MDLN annual earnings before interest & taxes is $2.23 billion

Annual EPS

$1.50
MDLN annual earnings per share is $1.50

Quarterly EBITDA:

$827.00M-$52.00M(-5.92%)
September 1, 2025

Summary

  • As of today, MDLN quarterly EBITDA is $827.00 million, with the most recent change of -$52.00 million (-5.92%) on September 1, 2025.
  • Over the past year, MDLN quarterly EBITDA has increased by +$5.00 million (+0.61%).
  • MDLN quarterly EBITDA is now -5.92% below its all-time high of $879.00 million, reached on June 1, 2025.

Performance

3-Month Change

-5.92%

1-Year Change

+0.61%

3-Year Change

+3.12%

5-Year Change

+3.12%

MDLN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

96.31%
MDLN quarterly EBITDA is higher than 96.31% of companies in Healthcare sector

Range

All-Time High

$879.00M
MDLN quarterly EBITDA is currently -5.92% below its historical high of $879.00 million

3-Year Low

$755.00M
MDLN quarterly EBITDA is currently +9.54% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2025
MDLN previous earnings announcement was published on Sep 1, 2025

Next Quarterly Earnings Report Date

Dec 25, 2025
MDLN next earnings announcement is scheduled for Dec 25, 2025

OtherMDLNincome statement metrics

Quarterly Revenue

$7.12B
MDLN quarterly revenue is $7.12 billion

Quarterly Net Income

$322.00M
MDLN quarterly net profit is $322.00 million

Quarterly EBIT

$574.00M
MDLN quarterly earnings before interest & taxes is $574.00 million

Quarterly EPS

$0.40
MDLN quarterly earnings per share is $0.40

TTM EBITDA:

$3.37B+$5.00M(+0.15%)
September 1, 2025

Summary

  • As of today, MDLN TTM EBITDA is $3.37 billion, with the most recent change of +$5.00 million (+0.15%) on September 1, 2025.
  • Over the past year, MDLN TTM EBITDA has increased by +$989.00 million (+41.57%).
  • MDLN TTM EBITDA is now at all-time high.

Performance

3-Month Change

+0.15%

1-Year Change

+41.57%

3-Year Change

+319.95%

5-Year Change

+319.95%

MDLN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

96.49%
MDLN TTM EBITDA is higher than 96.49% of companies in Healthcare sector

Range

All-Time High

$3.37B
MDLN TTM EBITDA is currently at an all-time high

3-Year Low

$802.00M
MDLN TTM EBITDA is currently +319.95% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2025
MDLN previous earnings announcement was published on Sep 1, 2025

Next Quarterly Earnings Report Date

Dec 25, 2025
MDLN next earnings announcement is scheduled for Dec 25, 2025

OtherMDLNincome statement metrics

TTM Revenue

$27.43B
MDLN TTM revenue is $27.43 billion

TTM Net Income

$1.27B
MDLN TTM net profit is $1.27 billion

TTM EBIT

$2.37B
MDLN TTM earnings before interest & taxes is $2.37 billion

TTM EPS

$1.58
MDLN TTM earnings per share is $1.58

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$3.20B
MDLN annual EBITDA is $3.20 billion

Annual Net Income

$1.20B
MDLN annual net profit is $1.20 billion

Annual Interest Expense

$0.00
MDLN annual interest expense is $0.00

Annual Income Tax

$46.00M
MDLN annual income tax is $46.00 million

Annual D&A

$977.00M
MDLN annual D&A is $977.00 million

MDLN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+33.7%+0.6%+41.6%
3Y3 Years+77.6%+3.1%+319.9%
5Y5 Years+77.6%+3.1%+319.9%

MDLN EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+77.6%-5.9%+9.5%at high+319.9%
5Y5-Yearat high+77.6%-5.9%+9.5%at high+319.9%
All-TimeAll-Timeat high+77.6%-5.9%+9.5%at high+319.9%

MDLN EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$827.00M(-5.9%)
$3.37B(+0.1%)
Jun 2025
-
$879.00M(+4.9%)
$3.36B(+3.8%)
Mar 2025
-
$838.00M(+1.7%)
$3.24B(+1.1%)
Dec 2024
$3.20B
$824.00M(+0.2%)
$3.20B(+34.6%)
DateAnnualQuarterlyTTM
Sep 2024
-
$822.00M(+8.9%)
$2.38B(+52.8%)
Jun 2024
-
$755.00M(-5.9%)
$1.56B(+94.1%)
Mar 2024
-
$802.00M
$802.00M
Dec 2023
$2.40B(+32.8%)
-
-
Dec 2022
$1.80B
-
-

FAQ

  • What is Medline Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Medline Inc.?
  • What is Medline Inc. annual EBITDA year-on-year change?
  • What is Medline Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Medline Inc.?
  • What is Medline Inc. quarterly EBITDA year-on-year change?
  • What is Medline Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Medline Inc.?
  • What is Medline Inc. TTM EBITDA year-on-year change?

What is Medline Inc. annual EBITDA?

The current annual EBITDA of MDLN is $3.20B

What is the all-time high annual EBITDA for Medline Inc.?

Medline Inc. all-time high annual EBITDA is $3.20B

What is Medline Inc. annual EBITDA year-on-year change?

Over the past year, MDLN annual EBITDA has changed by +$807.00M (+33.70%)

What is Medline Inc. quarterly EBITDA?

The current quarterly EBITDA of MDLN is $827.00M

What is the all-time high quarterly EBITDA for Medline Inc.?

Medline Inc. all-time high quarterly EBITDA is $879.00M

What is Medline Inc. quarterly EBITDA year-on-year change?

Over the past year, MDLN quarterly EBITDA has changed by +$5.00M (+0.61%)

What is Medline Inc. TTM EBITDA?

The current TTM EBITDA of MDLN is $3.37B

What is the all-time high TTM EBITDA for Medline Inc.?

Medline Inc. all-time high TTM EBITDA is $3.37B

What is Medline Inc. TTM EBITDA year-on-year change?

Over the past year, MDLN TTM EBITDA has changed by +$989.00M (+41.57%)
On this page